Individuation Intervention for Chronic Kidney Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to test whether an individuation intervention can improve the quality of chronic kidney disease (CKD) care for patients with low socioeconomic status (SES) and to understand the mechanisms through which the intervention may improve care delivery and clinical outcomes. The study will involve nephrologists and their patients with CKD, with a focus on reducing healthcare disparities associated with low SES. Researchers will compare nephrologists who receive the individuation intervention with those in the control group to determine whether encouraging physicians to better understand their patients as unique individuals, rather than relying on assumptions associated with socioeconomic status, improves the quality of CKD care for patients with low SES.
Are You a Good Fit for This Trial?
This trial is for patients with chronic kidney disease who are being treated by nephrologists. The focus is on those from lower-income backgrounds to see if care can be improved and disparities reduced.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Implicit Bias Training Alone
- Individuation + Implicit Bias Training
Trial Overview
The study compares two approaches: one group of doctors gets training to recognize their own biases plus extra guidance on seeing each patient as an individual, while the other group receives only bias awareness training.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Implicit bias training + individuation
Implicit bias training alone
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.